Status:
COMPLETED
Rosiglitazone and Exercise in Patients With Type 2 Diabetes Mellitus
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
University of Athens
Conditions:
Type II Diabetes Mellitus
Eligibility:
All Genders
40-75 years
Phase:
PHASE4
Brief Summary
The aim of the present study is to investigate the influence of systemic exercise, rosiglitazone administration and combined pharmaceutical and lifestyle intervention on cardiovascular risk factors
Eligibility Criteria
Inclusion
- Type II diabetes mellitus
- Poor glycemic control
Exclusion
- Heart failure
- Renal disease
- Liver disease
- Cardiovascular event
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2006
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00306176
Start Date
January 1 2005
End Date
October 1 2006
Last Update
April 4 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AHEPA University Hospital of Thessaloniki
Thessaloniki, Thessaloniki, Greece, 54454